Orkun Kaymakçı
Orkun Kaymakçı is the Team Leader of the Polymers & Chemistry Technology Group at Arçelik R&D. He received his B.Sc. degree in Chemistry from Koç University and his M.Sc. degree from Macromolecular Science & Engineering from Virginia Tech. He completed his Ph.D. in Polymer Science & Technology from Istanbul Technical University.
Before joining to Arçelik, he worked at Massachusetts General Hospital-Harvard Medical School as a Biomedical Engineer on development of polymer based implants. He has been working for Arcelik Global for seven years. He has a distinctive research and development experience in diverse fields of polymer science and technology. His current primary research interest includes advanced recycling technologies and renewable polymers for home appliance applications. He has 14 patent applications and numerous papers and presentations in the field of polymers.
Allard Max
Allard became intrigued by aquatic pollution whilst working on the Delfino (the Italian word for dolphin) car project and wanting to off-set the car's footprint not by planting trees but by doing something valuable in the ocean.
Seemingly there was no existing method to attribute damage costs to water pollutants and so the marine pollution acquatrail was born with the help of marine scientist Prof. Roberto Danovaro and sustainability specialist Susannah Stewart.
Danovaro and Corinaldesi had just published the damage done to coral by sunscreens and Allard decided to establish Aethic and develop Sôvée with world’s only scientifically proven and patented eco-compatible sunscreen formula - 100% proven reef safe.
Aethic’s various products have been and/or are retailed on board Air Canada, Alitalia and KLM as well Whole Foods, Planet Organic and online with Victoriahealth.com, net-a-porter.com and krisshop.com
Marcia Taylor
Dr. Marcia Taylor is the Vice President in charge of Research at Treventis Corporation. She has enabled key assays in the discovery of small molecules to prevent formation of toxic oligomers. She has led her team through small molecule synthesis, activity, DMPK, preclinical, and toxicity studies on the road to a disease modifying treatment for diseases of protein misfolding. Dr. Taylor received a PhD in Biochemistry and Molecular Biology from Dalhousie University.
Travis Palmquist
Fahad Aziz
Romain Gaillard
